Published by
@ShahidNShah
@ShahidNShah
0-50Healthcare
50 Milk Street, 16th Floor, Boston, Massachusetts, 02109, United States
Carthera® is a spin-off from AP-HP, Greater Paris University Hospitals, the largest hospital group in Europe, and Sorbonne University. The company leverages the inventions of Professor Alexandre Carpentier, lead neurosurgeon at AP-HP, who has achieved worldwide recognition for his breakthrough developments in treating brain tumors.
Founded in 2010, Carthera® is headquartered at the Brain Institute (Institut du Cerveau, ICM) in Paris, with offices at the Bioparc Laennec business incubator in Lyon and a US subsidiary based in Boston. The company, led by Frederic Sottilini (CEO), works closely with renowned academic institutions in its field, like INSERM, Sorbonne University, AP-HP, Northwestern University, MD Anderson Cancer Center.
Our Ambition
We aim to change the future for patients with brain tumors or other severe brain diseases through the development of innovative therapeutic ultrasound-based solutions.
The BBB blocks the penetration, and thus potential therapeutic effects, of over 95% of small molecule and 100% of large molecule drugs in the brain. SonoCloud® uses the therapeutic potential of pulsed …
Posted Digital Therapies #digitaltherapeutic Computer-Brain Interface
Last Updated
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Dec 19, 2024 at 6:21am